Effects of RIP and NG-R1 on TGF-β1, TAK1, p38 MAPK, p-p38 MAPK and MEK3/6 in the heart tissue (n=8 per group). Expression levels of (A) TGF-β1, (B) TAK1, (C) p38 MAPK, (D) p-p38 MAPK and (E) MEK3/6 protein levels as determined by blot analysis using tubulin as a reference. *P<0.01 vs. the control group; θP<0.01 vs. the RIP group. RIP, remote ischemic postconditioning; NG-R1, notoginsenoside R1; TGF, transforming growth factor; TAK1, TGF-β activated kinase 1; MAPK, mitogen-activated protein kinase; p, phosphorylated; MEK, MAPK kinase.